leadf
logo-loader
viewCronos Group Inc

Cronos Group Inc first cannabis stock listed on Nasdaq

CEO Mike Gorenstein from Cronos Group (NASDAQ: CRON) tells Proactive Investors it's been a long process to get listed on Nasdaq but they've finally achieved their goal.

The company is dual listed in Canada and has production facilities there, but Gorenstein says Cronos wants to expand production into the U.S. once marijuana becomes legal at the federal level.

Quick facts: Cronos Group Inc

Price: 10.79 USD

NASDAQ:CRON
Market: NASDAQ
Market Cap: $3.86 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

PharmaDrug pursuing Orphan Drug Designation with FDA to use DMT in kidney...

PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) CEO Daniel Cohen tells Proactive it has filed an application with the FDA to receive an orphan drug designation for the use of DMT in preventing kidney injuries in patients undergoing kidney transplants. Cohen says the group aims to unlock the potential...

13 hours, 45 minutes ago

2 min read